Med-tech and Healthcare Stocks With Upside During 2Q Earnings - Baird
Express News | Silk Road Medical Inc : Stifel Raises Target Price to $27.5 From $23
Express News | Silk Road Medical Inc : Stifel Cuts to Hold From Buy
Express News | Stifel Downgrades Silk Road Medical to Hold, Raises Price Target to $27.5
Stifel Downgrades Silk Road Medical(SILK.US) to Hold Rating, Raises Target Price to $27.5
Stifel analyst Rick Wise downgrades $Silk Road Medical(SILK.US)$ to a hold rating, and adjusts the target price from $23 to $27.5.According to TipRanks data, the analyst has a success rate of 57.9%
Argus Research Downgrades Silk Road Medical(SILK.US) to Sell Rating
Argus Research analyst David Toung downgrades $Silk Road Medical(SILK.US)$ to a sell rating.According to TipRanks data, the analyst has a success rate of 62.0% and a total average return of 9.3%
Argus Research Downgrades Silk Road Medical to Sell
Argus Research analyst Steve Silver downgrades Silk Road Medical (NASDAQ:SILK) from Buy to Sell.
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Silk Road Medical, Inc. Buyout
Wilmington, Delaware--(Newsfile Corp. - June 27, 2024) - Rigrodsky Law, P.A. is investigating Silk Road Medical, Inc. ("Silk Road") (NASDAQ: SILK) regarding possible breaches of fiduciary duties and o
Express News | Boston Scientific To Acquire Silk Road Medical For $1.16B In Cash, Offering $44 Per Share; 30% Premium Over Last Closing Price; Deal To Enhance Neurovascular Portfolio And Close By Q4 2024 Pending Regulatory Approvals
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersSonoma Pharmaceuticals (NASDAQ:SNOA) shares rose 60.2% to $0.27 during Wednesday's pre-market session. The market value of their outstanding shares is at $4.2 million. As per the press release,
Strength Seen in Silk Road Medical (SILK): Can Its 24.0% Jump Turn Into More Strength?
Silk Road Medical Cut to Hold From Buy by Lake Street
Silk Road Medical Cut to Hold From Buy by Lake Street
Lake Street Downgrades Silk Road Medical to Hold, Lowers Price Target to $27.5
Lake Street analyst Frank Takkinen downgrades Silk Road Medical (NASDAQ:SILK) from Buy to Hold and lowers the price target from $28 to $27.5.
Silk Road Medical Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/18/2024 2.38% Lake Street $28 → $27.5 Downgrades Buy → Hold 05/01/2024 -21.82% JP Morgan $19 → $21 Main
Health Care Climbs Amid Deal Activity - Health Care Roundup
Health-care companies ticked up amid deal activity. Boston Scientific has struck a deal to buy medical-device maker Silk Road Medical for about $1.26 billion, adding a technology for stroke preventio
Express News | Silk Road Medical-Upon Deal Termination Under Specified Circumstances, Co to Be Required to Pay Boston Scientific Termination Fee of $37.9 Mln
Express News | Silk Road Medical: Boston Scientific to Be Required to Pay Co Termination Fee of $69.5 Mln IF Merger Agreement Terminated Under Certain Circumstances
Sector Update: Health Care Stocks Edge Higher in Afternoon Trading
Health care stocks were edging up Tuesday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each rising about 0.1%. The iShares Biotechnology ETF (IBB) was d
Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Quantum Corporation (NASDAQ:QMCO) fell sharply during Tuesday's session after the company reported worse-than-expected FY24 financial results and issued FY25 guidance below estimates.Quantum
Slowing Retail Sales Growth, Stronger Industrial Production Set Stage for Mixed Trading in US Equities
US equity indexes traded mixed after a slower-than-expected increase in retail sales coincided with faster-than-anticipated growth in industrial production. The S&P 500 climbed 0.1% to 5,478.2, the Na